SYNOPSIS

Research at the Melbourne Children’s Campus was recently described in the New England Journal of Medicine as ‘leading to a paradigm shift in our understanding of lung disease in cystic fibrosis’. This comes at a time of major advances in our ability to treat people with CF. Lessons learnt from CF research and clinical care will resonate with all those caring for children with chronic conditions. In this talk some of the new and exciting therapeutic advances will be presented. This calls for a clinical approach targeting disease prevention, rather than just mitigation.

SPEAKERS

Sarath Ranganathan, MBChB, FRACP, PhD is Director of Respiratory Medicine at RCH, Head of Respiratory Research Group, MCRI and Principle Fellow, Department of Paediatrics at the University of Melbourne. He is Chair of the Australian CF Centre Directors. His current interests are in early detection of lung disease and quality improvement in cystic fibrosis.